Corlopam (Hospira, Inc.)


Welcome to the PulseAid listing for the Corlopam drug offered from Hospira, Inc.. This Dopamine Agonists [MoA],Dopaminergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Hospira, Inc.
NON-PROPRIETARY NAME: FENOLDOPAM MESYLATE
SUBSTANCE NAME: FENOLDOPAM MESYLATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Dopamine Agonists [MoA],Dopaminergic Agonist [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2005-02-28
END MARKETING DATE: 0000-00-00


Corlopam HUMAN PRESCRIPTION DRUG Details:

Item DescriptionCorlopam from Hospira, Inc.
LABELER NAME: Hospira, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 10(mg/mL)
START MARKETING DATE: 2005-02-28
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0409-2304_eb239f60-ec8e-42f6-8211-90cefadba174
PRODUCT NDC: 0409-2304
APPLICATION NUMBER: NDA019922

Other FENOLDOPAM MESYLATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Hospira, Inc.Corlopam